Loading...
Sonic Healthcare Limited
SHL.AX•ASX
Healthcare
Medical - Diagnostics & Research
A$26.79
A$0.00(0.00%)
Sonic Healthcare Limited (SHL.AX) Financial Performance & Statements
Review Sonic Healthcare Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
12.17%
↑ 12.17%
Operating Income Growth
-0.47%
↓ 0.47%
Net Income Growth
-25.39%
↓ 25.39%
Operating Cash Flow Growth
-27.16%
↓ 27.16%
Operating Margin
30.28%
↑ 30.28%
Gross Margin
33.05%
↑ 33.05%
Net Profit Margin
5.85%
↑ 5.85%
ROE
6.77%
↑ 6.77%
ROIC
21.49%
↑ 21.49%
Sonic Healthcare Limited (SHL.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Sonic Healthcare Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $4.66B | $4.27B | $3.94B | $4.04B |
| Cost of Revenue | $3.11B | $3.20B | $2.97B | $2.88B |
| Gross Profit | $1.56B | $1.07B | $964.78M | $1.16B |
| Gross Profit Ratio | $0.33 | $0.25 | $0.25 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $127.27M | $735.71M | $673.90M | $624.96M |
| Operating Expenses | $127.27M | $735.71M | $673.90M | $624.96M |
| Total Costs & Expenses | $3.23B | $3.94B | $3.65B | $3.50B |
| Interest Income | $12.30M | $12.46M | $9.20M | $4.42M |
| Interest Expense | $85.94M | $65.41M | $44.94M | $42.09M |
| Depreciation & Amortization | $393.64M | $383.66M | $357.31M | $345.62M |
| EBITDA | $910.18M | $749.12M | $356.28M | $924.61M |
| EBITDA Ratio | $0.20 | $0.17 | $0.16 | $0.22 |
| Operating Income | $1.43B | $333.51M | $290.88M | $534.46M |
| Operating Income Ratio | $0.31 | $0.08 | $0.07 | $0.13 |
| Other Income/Expenses (Net) | -$998.30M | -$33.46M | -$876.86M | -$817.35M |
| Income Before Tax | $430.60M | $300.05M | $394.28M | $536.91M |
| Income Before Tax Ratio | $0.09 | $0.07 | $0.10 | $0.13 |
| Income Tax Expense | $104.93M | $81.91M | $78.63M | $144.62M |
| Net Income | $308.78M | $202.31M | $302.63M | $382.35M |
| Net Income Ratio | $0.07 | $0.05 | $0.08 | $0.09 |
| EPS | $0.65 | $0.43 | $0.65 | $0.81 |
| Diluted EPS | $0.65 | $0.43 | $0.64 | $0.81 |
| Weighted Avg Shares Outstanding | $476.10M | $473.43M | $469.08M | $470.32M |
| Weighted Avg Shares Outstanding (Diluted) | $476.99M | $474.71M | $471.98M | $472.81M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan